Silicon Investor (SI) -- The First Internet Community

STOCKTALK

POLITICS
PASTIMES

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (16792)	5/15/2005 6:59:25 PM
From: rkrw	Respond to of 52153

Likewise, I think its anti-hyperbole to claim they need everything in their pipeline to succeed to justify the current share price. That would place the fair value somewhere well south of zero. One concern is surely vivitrex, been taking forever to sign that deal, usually not a good sign. ceo is clever though, I won't be surprised to see them do something non traditional or even m&a.